{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:57:27Z","timestamp":1792468647454,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.revmed.2016.10.388","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T11:32:09Z","timestamp":1479900729000},"page":"383-392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["D\u00e9ficit immunitaire primitif de l\u2019adulte et auto-immunit\u00e9"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0615-5305","authenticated-orcid":false,"given":"A.","family":"Guffroy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8658-8604","authenticated-orcid":false,"given":"V.","family":"Gies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.-S.","family":"Korganow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2016.10.388_bib0380","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10875-015-0198-5","article-title":"The 2015 IUIS phenotypic classification for primary immunodeficiencies","volume":"35","author":"Bousfiha","year":"2015","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.revmed.2016.10.388_bib0385","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","article-title":"Morbidity and mortality in common variable immune deficiency over 4 decades","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2016.10.388_bib0390","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaut.2010.10.002","article-title":"Autoimmunity in common variable immunodeficiency: correlation with lymphocyte phenotype in the French DEFI study","volume":"36","author":"Boileau","year":"2011","journal-title":"J Autoimmun"},{"key":"10.1016\/j.revmed.2016.10.388_bib0395","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.cell.2016.06.024","article-title":"AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies","volume":"166","author":"Meyer","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.revmed.2016.10.388_bib0400","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","article-title":"The EUROclass trial: defining subgroups in common variable immunodeficiency","volume":"111","author":"Wehr","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2016.10.388_bib0405","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1182\/blood-2014-06-583260","article-title":"Autoimmune and other cytopenias in primary immunodeficiencies: pathomechanisms, novel differential diagnoses, and treatment","volume":"124","author":"Seidel","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2016.10.388_bib0410","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1182\/blood-2011-04-347641","article-title":"A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation","volume":"118","author":"Neven","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2016.10.388_bib0415","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common variable immunodeficiency disorders: division into distinct clinical phenotypes","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2016.10.388_bib0420","series-title":"Management of autoimmunity and inflammation. Stiehms Immune Defic.","first-page":"931","author":"Verbsky","year":"2014"},{"key":"10.1016\/j.revmed.2016.10.388_bib0425","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/cid\/civ1220","article-title":"Progressive multifocal leukoencephalopathy in primary immune deficiencies: Stat1 gain of function and review of the literature","volume":"62","author":"Zerbe","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.revmed.2016.10.388_bib0430","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.revmed.2012.02.005","article-title":"Granulomatoses au cours des d\u00e9ficits immunitaires primitifs de l\u2019adulte","volume":"34","author":"Pavic","year":"2013","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2016.10.388_bib0435","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jaci.2004.05.057","article-title":"Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency","volume":"114","author":"Bates","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.revmed.2016.10.388_bib0440","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.imlet.2004.10.022","article-title":"A causal link between lymphopenia and autoimmunity","volume":"98","author":"Khoruts","year":"2005","journal-title":"Immunol Lett"},{"key":"10.1016\/j.revmed.2016.10.388_bib0445","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.clim.2015.05.020","article-title":"Application of whole genome and RNA sequencing to investigate the genomic landscape of common variable immunodeficiency disorders","volume":"160","author":"Van Schouwenburg","year":"2015","journal-title":"Clin Immunol"},{"key":"10.1016\/j.revmed.2016.10.388_bib0450","doi-asserted-by":"crossref","first-page":"11554","DOI":"10.1073\/pnas.1102600108","article-title":"Activation-induced cytidine deaminase (AID) is required for B cell tolerance in humans","volume":"108","author":"Meyers","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.revmed.2016.10.388_bib0455","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3109\/08916934.2012.750299","article-title":"Potential roles of activation-induced cytidine deaminase in promotion or prevention of autoimmunity in humans","volume":"46","author":"Durandy","year":"2013","journal-title":"Autoimmunity"},{"key":"10.1016\/j.revmed.2016.10.388_bib0460","doi-asserted-by":"crossref","first-page":"e3033","DOI":"10.1371\/journal.pone.0003033","article-title":"Activation-induced cytidine deaminase deficiency causes organ-specific autoimmune disease","volume":"3","author":"Hase","year":"2008","journal-title":"PloS One"},{"key":"10.1016\/j.revmed.2016.10.388_bib0465","first-page":"213","article-title":"Signalling pathways in B cells: implications for autoimmunity","volume":"305","author":"D\u00f6rner","year":"2006","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.revmed.2016.10.388_bib0470","doi-asserted-by":"crossref","first-page":"7305","DOI":"10.4049\/jimmunol.1000434","article-title":"B cell receptor-mediated calcium signaling is impaired in B lymphocytes of type Ia patients with common variable immunodeficiency","volume":"184","author":"Foerster","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.revmed.2016.10.388_bib0475","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1084\/jem.20110200","article-title":"WASp-deficient B cells play a critical, cell-intrinsic role in triggering autoimmunity","volume":"208","author":"Becker-Herman","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.revmed.2016.10.388_bib0480","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1056\/NEJMoa051568","article-title":"An antibody deficiency syndrome due to mutations in the CD19 gene","volume":"354","author":"Van Zelm","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2016.10.388_bib0485","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1172\/JCI40231","article-title":"CD20 deficiency in humans results in impaired T cell\u2013independent antibody responses","volume":"120","author":"Kuijpers","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2016.10.388_bib0490","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jaci.2011.09.027","article-title":"Genetic CD21 deficiency is associated with hypogammaglobulinemia","volume":"129","author":"Thiel","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.revmed.2016.10.388_bib0495","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jaci.2011.12.982","article-title":"CD21 deficiency, complement, and the development of common variable immunodeficiency","volume":"129","author":"Frank","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.revmed.2016.10.388_bib0500","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1172\/JCI39748","article-title":"CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency","volume":"120","author":"Van Zelm","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2016.10.388_bib0505","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1172\/JCI75746","article-title":"A human immunodeficiency caused by mutations in the PIK3R1 gene","volume":"124","author":"Deau","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2016.10.388_bib0510","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jaci.2016.03.022","article-title":"Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase \u03b4 syndrome 2: a cohort study","volume":"138","author":"Elkaim","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.revmed.2016.10.388_bib0515","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1744-313X.2006.00627.x","article-title":"Identification of variations in the human phosphoinositide 3-kinase p110delta gene in children with primary B cell immunodeficiency of unknown aetiology","volume":"33","author":"Jou","year":"2006","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.revmed.2016.10.388_bib0520","article-title":"Clinical spectrum and features of activated PI3-kinase delta syndrome: a large patient cohort study","author":"Coulter","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.revmed.2016.10.388_bib0525","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ni.2771","article-title":"Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110\u03b4 result in T cell senescence and human immunodeficiency","volume":"15","author":"Lucas","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.revmed.2016.10.388_bib0530","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaci.2015.11.004","article-title":"The crossroads of autoimmunity and immunodeficiency: lessons from polygenic traits and monogenic defects","volume":"137","author":"Grimbacher","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.revmed.2016.10.388_bib0535","doi-asserted-by":"crossref","DOI":"10.1007\/s10875-016-0294-1","article-title":"Autoimmunity and primary immunodeficiency disorders","author":"Allenspach","year":"2016","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.revmed.2016.10.388_bib0540","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s11882-014-0462-4","article-title":"Autoimmune lymphoproliferative syndrome: an update and review of the literature","volume":"14","author":"Shah","year":"2014","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.revmed.2016.10.388_bib0545","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11033-012-2075-0","article-title":"Association of Fas gene polymorphisms with systemic lupus erythematosus: a meta-analysis","volume":"40","author":"Xiang","year":"2013","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.revmed.2016.10.388_bib0550","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1172\/JCI118892","article-title":"Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease","volume":"98","author":"Wu","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2016.10.388_bib0555","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2249.2007.03321.x","article-title":"Cutaneous and other lupus-like symptoms in carriers of X-linked chronic granulomatous disease: incidence and autoimmune serology","volume":"148","author":"Cale","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.revmed.2016.10.388_bib0560","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/jmg.39.8.537","article-title":"Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome","volume":"39","author":"Wildin","year":"2002","journal-title":"J Med Genet"},{"key":"10.1016\/j.revmed.2016.10.388_bib0565","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/83713","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume":"27","author":"Bennett","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.revmed.2016.10.388_bib0570","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.20091669","article-title":"Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines","volume":"207","author":"Kisand","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.revmed.2016.10.388_bib0575","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1126\/science.1255904","article-title":"Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4","volume":"345","author":"Kuehn","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.revmed.2016.10.388_bib0580","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.3746","article-title":"Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations","volume":"20","author":"Schubert","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.revmed.2016.10.388_bib0585","doi-asserted-by":"crossref","first-page":"19396","DOI":"10.1073\/pnas.0806855105","article-title":"Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis","volume":"105","author":"Flores-Borja","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.revmed.2016.10.388_bib0590","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/eji.200939781","article-title":"Abnormal CTLA-4 function in T cells from patients with systemic lupus erythematosus","volume":"40","author":"Jury","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.revmed.2016.10.388_bib0595","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.aaa1663","article-title":"Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy","volume":"349","author":"Lo","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.revmed.2016.10.388_bib0600","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jaci.2015.09.025","article-title":"The extended phenotype of LPS-responsive Beige-like anchor protein (LRBA) deficiency","volume":"137","author":"G\u00e1mez-D\u00edaz","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.revmed.2016.10.388_bib0605","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jaci.2012.05.043","article-title":"LPS-responsive Beige-like anchor (LRBA) gene mutation in a family with inflammatory bowel disease and combined immunodeficiency","volume":"130","author":"Alangari","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.revmed.2016.10.388_bib0610","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1172\/JCI79100","article-title":"Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations","volume":"124","author":"Jeremiah","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2016.10.388_bib0615","doi-asserted-by":"crossref","first-page":"e74893","DOI":"10.1371\/journal.pone.0074893","article-title":"Interferon signature in the blood in inflammatory common variable immune deficiency","volume":"8","author":"Park","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.revmed.2016.10.388_bib0620","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s10875-011-9602-y","article-title":"TLR-mediated B cell defects and IFN-\u03b1 in common variable immunodeficiency","volume":"32","author":"Yu","year":"2012","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.revmed.2016.10.388_bib0625","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.jaci.2012.11.054","article-title":"Dominant gain of function STAT1 mutations in FOXP3 wild-type immune dysregulation polyendocrinopathy enteropathy-X-linked-like syndrome","volume":"131","author":"Uzel","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.revmed.2016.10.388_bib0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2016.05.007","article-title":"Distinct mutations at the same positions of STAT3 cause either loss or gain of function","author":"Chandrasekaran","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.revmed.2016.10.388_bib0675","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/40618","article-title":"Evolution of genetic redundancy","volume":"388","author":"Nowak","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.revmed.2016.10.388_bib0680","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.gde.2014.07.004","article-title":"The Red Queen's long race: human adaptation to pathogen pressure","volume":"29","author":"Siddle","year":"2014","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.revmed.2016.10.388_bib0685","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.it.2015.12.006","article-title":"Primary immunodeficiencies and inflammatory disease: a growing genetic intersection","volume":"37","author":"Fodil","year":"2016","journal-title":"Trends Immunol"},{"key":"10.1016\/j.revmed.2016.10.388_bib0690","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1086\/657308","article-title":"Complications of tumor necrosis factor-\u03b1 blockade in chronic granulomatous disease-related colitis","volume":"51","author":"Uzel","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.revmed.2016.10.388_bib0695","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.smim.2014.09.008","article-title":"Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-\u03b3 immunity","volume":"26","author":"Bustamante","year":"2014","journal-title":"Semin Immunol"},{"key":"10.1016\/j.revmed.2016.10.388_bib0700","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1586\/eci.11.6","article-title":"The risk of tuberculosis in patients treated with TNF antagonists","volume":"7","author":"Salgado","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.revmed.2016.10.388_bib0705","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jaip.2015.07.001","article-title":"The ratio of mean daily IgG increment\/mean daily dose in immunoglobulin replacement therapy in primary antibody deficiencies","volume":"3","author":"Lucas","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.revmed.2016.10.388_bib0710","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/MD.0b013e31817a90ba","article-title":"Autoimmune hemolytic anemia and common variable immunodeficiency: a case-control study of 18 patients","volume":"87","author":"S\u00e8ve","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2016.10.388_bib0715","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/cei.12039","article-title":"Clinical Working Party of the European Society for Immunodeficiencies (ESID). Outcomes of splenectomy in patients with common variable immunodeficiency (CVID): a survey of 45 patients","volume":"172","author":"Wong","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.revmed.2016.10.388_bib0720","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1136\/bmj.1.6021.1314","article-title":"Polyarthritis in adults with hypogammaglobulinaemia and its rapid response to immunoglobulin treatment","volume":"1","author":"Webster","year":"1976","journal-title":"Br Med J"},{"key":"10.1016\/j.revmed.2016.10.388_bib0725","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood-2015-07-657981","article-title":"Sirolimus is effective in relapsed\/refractory autoimmune cytopenias: results of a prospective multi-institutional trial","volume":"127","author":"Bride","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2016.10.388_bib0730","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1182\/blood-2015-05-645077","article-title":"Administration of interleukin-7 increases CD4T cells in idiopathic CD4 lymphocytopenia","volume":"127","author":"Sheikh","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2016.10.388_bib0735","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jaci.2013.04.018","article-title":"Continuous G-CSF therapy for isolated chronic mucocutaneous candidiasis: complete clinical remission with restoration of IL-17 secretion","volume":"132","author":"Wildbaum","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.revmed.2016.10.388_bib0740","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jaci.2014.11.029","article-title":"Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency","volume":"135","author":"Wehr","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.revmed.2016.10.388_bib0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2016.01.045","article-title":"Hematopoietic stem cell transplantation for CTLA4 deficiency","author":"Slatter","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.revmed.2016.10.388_bib0335","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/petr.12667","article-title":"Successful reduced-intensity stem cell transplantation for GATA2 deficiency before progression of advanced MDS","volume":"20","author":"Saida","year":"2016","journal-title":"Pediatr Transplant"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866316309699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866316309699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:37:54Z","timestamp":1759336674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866316309699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":67,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0248866316309699"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2016.10.388","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"D\u00e9ficit immunitaire primitif de l\u2019adulte et auto-immunit\u00e9","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2016.10.388","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}